| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T603 |
0-142 |
Sentence |
denotes |
However, at the same time, these cross-reactive antibodies should also have neutralizing property; otherwise, they will have a harmful effect. |
| T604 |
143-267 |
Sentence |
denotes |
A recent study explored the cross-reactive and neutralization property of these antibodies simultaneously (Lv et al., 2020). |
| T605 |
268-474 |
Sentence |
denotes |
This study used plasma from 15 SARS-CoV-2 and 7 SARS-CoV patients and found a high degree of cross-reactivity between the antibody response from these samples, but a very low antibody neutralizing property. |
| T606 |
475-556 |
Sentence |
denotes |
These results were further confirmed in animal models of SARS-CoV-2 and SARS-CoV. |
| T607 |
557-735 |
Sentence |
denotes |
While S309 antibody showed better neutralization property against SARS-CoV-2, the neutralization properties for CR3022 are not yet known (Pinto et al., 2020; Wang et al., 2020a). |
| T608 |
736-934 |
Sentence |
denotes |
Thus, although a high degree of cross-reactivity of the antibody response from SARS-CoV-2 can be found with other related CoVs, the neutralizing property of these antibodies may be epitope specific. |
| T609 |
935-1161 |
Sentence |
denotes |
The weak neutralizing property of such cross-reactive antibodies should thoroughly be tested before usage as a therapeutic intervention, to prevent the complications which may arise due to antibody-dependent enhancement (ADE). |
| T610 |
1162-1244 |
Sentence |
denotes |
These factors also become essential while considering convalescent plasma therapy. |
